Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

593 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ; VIGOR Study Group. Bombardier C, et al. Among authors: kvien tk. N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103. N Engl J Med. 2000. PMID: 11087881 Clinical Trial.
[Rheumatoid arthritis].
Brekke M, Kvien TK. Brekke M, et al. Among authors: kvien tk. Tidsskr Nor Laegeforen. 1999 Apr 30;119(11):1575. Tidsskr Nor Laegeforen. 1999. PMID: 10385796 Norwegian. No abstract available.
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.
Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS. Emery P, et al. Among authors: kvien tk. Lancet. 1999 Dec 18-25;354(9196):2106-11. doi: 10.1016/S0140-6736(99)02332-6. Lancet. 1999. PMID: 10609815 Clinical Trial.
Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
Kristiansen IS, Kvien TK, Nord E. Kristiansen IS, et al. Among authors: kvien tk. Arthritis Rheum. 1999 Nov;42(11):2293-302. doi: 10.1002/1529-0131(199911)42:11<2293::AID-ANR6>3.0.CO;2-1. Arthritis Rheum. 1999. PMID: 10555023
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R. Smolen JS, et al. Among authors: kvien tk. Lancet. 1999 Jan 23;353(9149):259-66. doi: 10.1016/s0140-6736(98)09403-3. Lancet. 1999. PMID: 9929017 Clinical Trial.
Epidemiology of disability in rheumatoid arthritis.
Kvien TK. Kvien TK. Rheumatology (Oxford). 2002 Feb;41(2):121-3. doi: 10.1093/rheumatology/41.2.121. Rheumatology (Oxford). 2002. PMID: 11886956 Review. No abstract available.
[The handling of drugs for a clinical trial].
Kvien TK, Høyeraal HM, Reimers S. Kvien TK, et al. Tidsskr Nor Laegeforen. 1982 Apr 20;102(11):617-9. Tidsskr Nor Laegeforen. 1982. PMID: 7157238 Norwegian. No abstract available.
[Leflunomide--a new disease modifying anti-rheumatic agent].
Rødevand E, Kvien TK, Johnsen V. Rødevand E, et al. Among authors: kvien tk. Tidsskr Nor Laegeforen. 2001 Nov 10;121(27):3181-4. Tidsskr Nor Laegeforen. 2001. PMID: 11876141 Review. Norwegian.
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I; European Leflunomide Study Group. Scott DL, et al. Among authors: kvien tk. Ann Rheum Dis. 2001 Oct;60(10):913-23. doi: 10.1136/ard.60.10.913. Ann Rheum Dis. 2001. PMID: 11557646 Free PMC article. Clinical Trial.
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
Kalden JR, Scott DL, Smolen JS, Schattenkirchner M, Rozman B, Williams BD, Kvien TK, Jones P, Williams RB, Oed C, Rosenburg R; European Leflunomide Study Group. Kalden JR, et al. Among authors: kvien tk. J Rheumatol. 2001 Sep;28(9):1983-91. J Rheumatol. 2001. PMID: 11550964 Clinical Trial.
593 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback